PubMed HealthSearch

Biomedical subjects

D Treit

Publications and source records attributed to D Treit.

6 recordsLinked to original sources

Excitotoxic lesions of the septum produce anxiolytic effects in the elevated plus-maze and the shock-probe burying tests.

Our previous research has shown that electrolytic lesions of the posterior septum result in dramatic, antianxiety effects in two different animal models of anxiolytic drug action, i.e., a selective increase in open-arm activity in the elevated plus-maze test, and a selective abolition of defensive burying in the shock-probe burying test. Although these results suggest that posterior regions of the septum play an important role in the expression of anxiety in these tests, it is unclear whether destruction of septal nuclei themselves mediated these effects, since electrolytic lesions also destroy fibers of passage. Accordingly, in the present experiments, the anxiolytic effects of electrolytic lesions of the septum were compared to those of excitotoxic lesions, which preferentially destroy cell bodies, leaving fibers of passage intact. In the first experiment, both electrolytic and kainic acid lesions of the posterior septum produced complete anxiolytic effects in the elevated plus-maze (an increase in the percentage of open-arm entries and percentage of time in open arms), and partial anxiolytic effects in the shock-probe test (an increase in contact-induced probe shocks), compared to sham-lesioned controls. These antianxiety effects could not be attributed to an increase in general activity, or a decrease in reactivity to shock. In the second experiment, excitotoxic lesions of the posterior septum were produced by a more selective agent, quisqualic acid. Quisqualic acid, like electrolytic lesions, produced clear, anxiolytic effects in both the plus-maze and the shock-probe tests, compared to sham-lesioned control. Taken together, these results strongly suggest that cells originating in posterior regions of the septum mediate anxiety-related responses.

Animals

Septal lesions inhibit fear reactions in two animal models of anxiolytic drug action.

The role of the septum in anxiety was studied using two different animal models of antianxiety drug action; i.e., the shock probe-burying test and the elevated plus maze test. Antianxiety effects were observed in both paradigms (i.e., a decrease in probe burying, and an increase in open arm activity) after lesions of the entire septum, compared to sham-lesioned controls (Experiment 1). No differences between lesioned and sham-lesioned rats were found in general activity, shock reactivity, or handling reactivity at the time of the antianxiety tests. A second experiment showed that the antianxiety effects observed in the two paradigms were anatomically specific, since lesions of the posterior septum decreased both indices of anxiety (probe burying and open arm avoidance), whereas lesions of the anterior septum resulted in levels of anxiety that were comparable to those displayed by sham-lesioned controls. Taken together, these results provide convergent evidence that posterior regions of the septum play an important role in the control of anxiety in the rat.

Agonistic Behavior

A comparison of benzodiazepine, serotonin, and dopamine agents in the taste-reactivity paradigm.

Previous studies have shown that rats' positive, palatability-dependent consummatory reactions to infused tastes are selectively facilitated by a benzodiazepine agonist (chlordiazepoxide), and that this effect can be blocked by the coadministration of benzodiazepine antagonists (e.g., Ro 15-1788). The purpose of the present study was to determine whether agents acting at other receptor sites (dopaminergic, serotonergic), which have been shown to modulate food consumption, might also modify rats' palatability-dependent reactivity to infused tastes. In this experiment, the benzodiazepine agonist, diazepam, facilitated positive palatability reactions, while dopaminergic agents (haloperidol, apomorphine, amphetamine) had no significant effects on either positive or aversive reactions. The putative 5-HT1A agonists, buspirone and gepirone, had a general inhibitory action on both positive and aversive palatability reactions. These results are surprising in view of the effects of serotonergic and dopaminergic agents on food and fluid intake. Our results suggest that the benzodiazepine receptor system may play a special role in the neural control of appetite through its enhancement of the positive palatability of tastes. Dopamine systems, by contrast, appear to control food intake by modulating processes that are independent of food affect evaluation.

Amphetamine

A comparison of anxiolytic and nonanxiolytic agents in the shock-probe/burying test for anxiolytics.

The effects of IP midazolam (1.0-3.0 mg/kg), pentobarbital (10-20 mg/kg), ethanol (500-2000 mg/kg), scopolamine (0.05-1.25 mg/kg), chlorpromazine (0.5-5.0 mg/kg), yohimbine (0.5-2.0 mg/kg), and pentylene-tetrazol (5.0-20.0 mg/kg) were compared in the shock-probe/burying test. Consistent with results found previously for chlordiazepoxide and buspirone, the anxiolytic agents midazolam and pentobarbital decreased rats' burying behavior toward a continuously electrified (2 mA) shock-probe, and increased the number of contact-induced probe-shocks rats received. A concurrent decrease in probe-burying and increase in probe-shocks was not reliably observed after ethanol, scopolamine, chlorpromazine, yohimbine, or pentylenetetrazol. Although most of these nonanxiolytic agents produced some suppression of burying behavior at high doses, none of these drugs induced a significant increase in probe-shocks. In fact, pentylenetetrazol, which is believed to be anxiogenic, produced a significant reduction in probe-shocks. Yohimbine, another putative anxiogenic agent, was not active in the present test. In summary, concurrent increases in probe-shocks and decreases in probe-burying seem to be characteristic effects of clinically useful anxiolytic agents, which distinguish them from nonanxiolytic agents.

Animals

Temporal lobe aggression in rats.

Although reports of aggressive behavior in temporal lobe epileptics are common, it has proven difficult in clinical settings to gain the experimental control necessary to systematically investigate temporal lobe aggression or even to provide unequivocal evidence of its existence. Increases in aggressive behavior were observed in rats with experimentally induced epileptic foci in temporal lobe structures but not in control rats or those with foci in the caudate.

Aggression